1. Home
  2. DYAI vs VRAR Comparison

DYAI vs VRAR Comparison

Compare DYAI & VRAR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • DYAI
  • VRAR
  • Stock Information
  • Founded
  • DYAI 1979
  • VRAR 2016
  • Country
  • DYAI United States
  • VRAR United States
  • Employees
  • DYAI N/A
  • VRAR N/A
  • Industry
  • DYAI Biotechnology: Biological Products (No Diagnostic Substances)
  • VRAR Retail: Computer Software & Peripheral Equipment
  • Sector
  • DYAI Health Care
  • VRAR Technology
  • Exchange
  • DYAI Nasdaq
  • VRAR Nasdaq
  • Market Cap
  • DYAI 29.6M
  • VRAR 33.3M
  • IPO Year
  • DYAI 2004
  • VRAR 2021
  • Fundamental
  • Price
  • DYAI $0.93
  • VRAR $1.44
  • Analyst Decision
  • DYAI Strong Buy
  • VRAR Strong Buy
  • Analyst Count
  • DYAI 1
  • VRAR 1
  • Target Price
  • DYAI $6.00
  • VRAR $2.62
  • AVG Volume (30 Days)
  • DYAI 60.7K
  • VRAR 121.6K
  • Earning Date
  • DYAI 08-12-2025
  • VRAR 05-15-2025
  • Dividend Yield
  • DYAI N/A
  • VRAR N/A
  • EPS Growth
  • DYAI N/A
  • VRAR N/A
  • EPS
  • DYAI N/A
  • VRAR N/A
  • Revenue
  • DYAI $3,554,344.00
  • VRAR $8,756,789.00
  • Revenue This Year
  • DYAI $22.56
  • VRAR $6.59
  • Revenue Next Year
  • DYAI $30.95
  • VRAR $30.43
  • P/E Ratio
  • DYAI N/A
  • VRAR N/A
  • Revenue Growth
  • DYAI 57.59
  • VRAR N/A
  • 52 Week Low
  • DYAI $0.91
  • VRAR $0.50
  • 52 Week High
  • DYAI $2.20
  • VRAR $7.00
  • Technical
  • Relative Strength Index (RSI)
  • DYAI 41.84
  • VRAR 54.25
  • Support Level
  • DYAI $0.91
  • VRAR $1.31
  • Resistance Level
  • DYAI $1.06
  • VRAR $1.38
  • Average True Range (ATR)
  • DYAI 0.06
  • VRAR 0.10
  • MACD
  • DYAI 0.00
  • VRAR 0.00
  • Stochastic Oscillator
  • DYAI 15.33
  • VRAR 69.70

About DYAI Dyadic International Inc.

Dyadic International Inc is a worldwide biotechnology platform company. It has developed a gene expression platform for producing commercial quantities of industrial enzymes and other proteins and has licensed this technology to third parties, such as Abengoa Bioenergy, BASF, Codexis and others, for use in industrial (non-pharmaceutical) applications. This technology is based on the Thermothelomyces heterothallica fungus, which the company named C1.

About VRAR The Glimpse Group Inc.

The Glimpse Group Inc is a diversified Virtual and Augmented Reality platform company, comprised of multiple VR and AR software and services companies, and designed with the specific purpose of cultivating companies in the emerging VR/AR industry.

Share on Social Networks: